Cell membrane camouflaged nanoparticles: a new biomimetic platform for cancer photothermal therapy

References

• Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agents Smancs. Cancer Res. 1986;46:1986.
   Web of Science ®Google Scholar
• Dai Y, Xu C, Sun X, Chen X. Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment. Chem Soc Rev. 2017;46(12):3830–3852. doi:10.1039/c6cs00592f28516983
   PubMed Web of Science ®Google Scholar
• Kranz LM, Diken M, Haas H, et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature. 2016;534(7607):396–401. doi:10.1038/nature1830027281205
   PubMed Web of Science ®Google Scholar
• Siefert AL, Caplan MJ, Fahmy TM. Artificial bacterial biomimetic nanoparticles synergize pathogen-associated molecular patterns for vaccine efficacy. Biomaterials. 2016;97:85–96. doi:10.1016/j.biomaterials.2016.03.03927162077
   PubMed Web of Science ®Google Scholar
• Giljohann DA, Seferos DS, Prigodich AE, Patel PC, Mirkin CA. Gene regulation with polyvalent siRNA-nanoparticle conjugates. J Am Chem Soc. 2009;131(6):2072–2073. doi:10.1021/ja808719p19170493
   PubMed Web of Science ®Google Scholar
• Ouay BL, Stellacci F. Antibacterial activity of silver nanoparticles: a surface science insight. Nano Today. 2015;10(3):339–354. doi:10.1016/j.nantod.2015.04.002
   Web of Science ®Google Scholar
• Amani H, Mostafavi E, Arzaghi H, et al. Three-dimensional graphene foams: synthesis, properties, biocompatibility, biodegradability, and applications in tissue engineering. ACS Biomater Sci Eng. 2019; 5(1): 193–214.
   Web of Science ®Google Scholar
• Tsao SC-H, Wang J, Wang Y, Behren A, Cebon J, Trau M. Characterising the phenotypic evolution of circulating tumour cells during treatment. Nat Commun. 2018;9:1. doi:10.1038/s41467-018-03725-829317637
   PubMedGoogle Scholar
• Kim HS, Lee DY. Near-infrared-responsive cancer photothermal and photodynamic therapy using gold nanoparticles. Polymers. 2018;10:9. doi:10.3390/polym10090961
   Web of Science ®Google Scholar
• Jabeen F, Najam-ul-Haq M, Javeed R, Huck CW, Bonn GK. Au-nanomaterials as a superior choice for near-infrared photothermal therapy. Molecules. 2014;19(12):20580–20593. doi:10.3390/molecules19122058025501919
   PubMedGoogle Scholar
• Zhao X, Qi T, Kong C, et al. Photothermal exposure of polydopamine-coated branched Au-Ag nanoparticles induces cell cycle arrest, apoptosis, and autophagy in human bladder cancer cells. Int J Nanomedicine. 2018;13:6413–6428. doi:10.2147/IJN.S17434930410328
   PubMed Web of Science ®Google Scholar
• Qi W, Yan J, Sun H, Wang H. Nanocomposite plasters for the treatment of superficial tumors by chemo-photothermal combination therapy. Int J Nanomedicine. 2018;13:6235–6247. doi:10.2147/IJN.S17020930349247
   PubMed Web of Science ®Google Scholar
• Shen S, Tang H, Zhang X, et al. Targeting mesoporous silica-encapsulated gold nanorods for chemo-photothermal therapy with near-infrared radiation. Biomaterials. 2013;34(12):3150–3158. doi:10.1016/j.biomaterials.2013.01.05123369218
   PubMed Web of Science ®Google Scholar
• Sung S-J, Min SH, Cho KY, et al. Effect of polyethylene glycol on gene delivery of polyethylenimine. Biol Pharm Bull. 2003;26(4):492–500.12673031
   PubMed Web of Science ®Google Scholar
• Inostroza-Riquelme M, Vivanco A, Lara P, et al. Encapsulation of gold nanostructures and oil-in-water nanocarriers in microgels with biomedical potential. Molecules. 2018;23:5. doi:10.3390/molecules23051208
   Web of Science ®Google Scholar
• Tang B, Qian Y, Gou Y, Cheng G, Fang G. VE-albumin core-shell nanoparticles for paclitaxel delivery to treat MDR breast cancer. Molecules. 2018;23:11. doi:10.3390/molecules23112760
   PubMed Web of Science ®Google Scholar
• Deloach J, Barton C, Culler K. Preparation of resealed carrier erythrocytes and in vivo survival in dogs. Am J Vet Res. 1981;42(4):667–669.7036804
   PubMed Web of Science ®Google Scholar
• Hu CMJ, Fang RH, Fang L. Erythrocyte‐inspired delivery systems. Adv Healthc Mater. 2012;1(5):537–547. doi:10.1002/adhm.20120013823184788
   PubMed Web of Science ®Google Scholar
• Cao B, Yang M, Zhu Y, Qu X, Mao C. Stem cells loaded with nanoparticles as a drug carrier for in vivo breast cancer therapy. Adv Mater Weinheim. 2014;26(27):4627–4631. doi:10.1002/adma.20140155024890678
   PubMed Web of Science ®Google Scholar
• Phua KKL, Boczkowski D, Dannull J, Pruitt S, Leong KW, Nair SK. Whole blood cells loaded with messenger RNA as an anti-tumor vaccine. Adv Healthc Mater. 2014;3(6):837–842. doi:10.1002/adhm.20130051224339387
   PubMed Web of Science ®Google Scholar
• Tan S, Wu T, Zhang D, Zhang Z. Cell or cell membrane-based drug delivery systems. Theranostics. 2015;5(8):863–881. doi:10.7150/thno.1185226000058
   PubMed Web of Science ®Google Scholar
• Namiki Y, Fuchigami T, Tada N, et al. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring. Acc Chem Res. 2011;44(10):1080–1093. doi:10.1021/ar200011r21786832
   PubMed Web of Science ®Google Scholar
• Reimhult E. Nanoparticle-triggered release from lipid membrane vesicles. New Biotechnol. 2015;32(6):665–672. doi:10.1016/j.nbt.2014.12.002
   PubMed Web of Science ®Google Scholar
• Sun D, Zhuang X, Zhang S, et al. Exosomes are endogenous nanoparticles that can deliver biological information between cells. Adv Drug Deliv Rev. 2013;65(3):342–347. doi:10.1016/j.addr.2012.07.00222776312
   PubMed Web of Science ®Google Scholar
• Li B, Wang F, Gui L, He Q, Yao Y, Chen H. The potential of biomimetic nanoparticles for tumor-targeted drug delivery. Nanomedicine (Lond). 2018;13:16. doi:10.2217/nnm-2018-0017
   Web of Science ®Google Scholar
• Fang RH, Hu C-MJ, Chen KNH, et al. Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles. Nanoscale. 2013;5(19):8884–8888. doi:10.1039/c3nr03064d23907698
   PubMed Web of Science ®Google Scholar
• Sheng G, Chen Y, Han L, et al. Encapsulation of indocyanine green into cell membrane capsules for photothermal cancer therapy. Acta Biomater. 2016;43:251–261. doi:10.1016/j.actbio.2016.07.01227422197
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhao P, Luo Z, et al. Cancer cell membrane-biomimetic nanoparticles for homologous-targeting dual-modal imaging and photothermal therapy. ACS Nano. 2016;10(11):10049. doi:10.1021/acsnano.6b0469527934074
   PubMed Web of Science ®Google Scholar
• Hu C-MJ, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci USA. 2011;108(27):10980–10985. doi:10.1073/pnas.110663410821690347
   PubMed Web of Science ®Google Scholar
• Peng J, Yang Q, Li W, et al. Erythrocyte-membrane-coated prussian blue/manganese dioxide nanoparticles as H2O2-responsive oxygen generators to enhance cancer chemotherapy/photothermal therapy. ACS Appl Mater Interfaces. 2017;9(51):44410–44422. doi:10.1021/acsami.7b1702229210279
   PubMedGoogle Scholar
• Krishnamurthy S, Gnanasammandhan MK, Xie C, Huang K, Cui MY, Chan JM. Monocyte cell membrane-derived nanoghosts for targeted cancer therapy. Nanoscale. 2016;8(13):6981–6985. doi:10.1039/c5nr07588b26975904
   PubMed Web of Science ®Google Scholar
• Crusz SM, Balkwill FR. Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol. 2015;12(10):584–596. doi:10.1038/nrclinonc.2015.10526122183
   PubMed Web of Science ®Google Scholar
• Li J, Zhen X, Lyu Y, Jiang Y, Huang J, Pu K. cell membrane coated semiconducting polymer nanoparticles for enhanced multimodal cancer phototheranostics. ACS Nano. 2018;12(8):8520–8530. doi:10.1021/acsnano.8b0406630071159
   PubMed Web of Science ®Google Scholar
• Jiang Q, Luo Z, Men Y, et al. Red blood cell membrane-camouflaged melanin nanoparticles for enhanced photothermal therapy. Biomaterials. 2017;143:29. doi:10.1016/j.biomaterials.2017.07.02728756194
   PubMed Web of Science ®Google Scholar
• Fu Q, Lv P, Chen Z, et al. Programmed co-delivery of paclitaxel and doxorubicin boosted by camouflaging with erythrocyte membrane. Nanoscale. 2015;7(9):4020–4030. doi:10.1039/c4nr07027e25653083
   PubMed Web of Science ®Google Scholar
• Kang T, Zhu Q, Wei D, et al. Nanoparticles coated with neutrophil membranes can effectively treat cancer metastasis. ACS Nano. 2017;11:1397−1411. doi:10.1021/acsnano.6b0647728075552
   PubMed Web of Science ®Google Scholar
• Zhang Q, Dehaini D, Zhang Y, et al. Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis. Nat Nanotechnol. 2018. 13;1182–1190.
   Web of Science ®Google Scholar
• Hu CMJ, Fang RH, Copp J, Luk BT, Zhang L. A biomimetic nanosponge that absorbs pore-forming toxins. Nat Nanotechnol. 2013;8(5):336–340. doi:10.1038/nnano.2013.5423584215
   PubMed Web of Science ®Google Scholar
• Hu CM, Fang RH, Luk BT, Zhang L. Nanoparticle-detained toxins for safe and effective vaccination. Nat Nanotechnol. 2013;8(12):933–938. doi:10.1038/nnano.2013.25424292514
   PubMed Web of Science ®Google Scholar
• Fitzgerald J, Foster T, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol. 2006;4(6):445. doi:10.1038/nrmicro142516710325
   PubMed Web of Science ®Google Scholar
• Ren X, Zheng R, Fang X, et al. Red blood cell membrane camouflaged magnetic nanoclusters for imaging-guided photothermal therapy. Biomaterials. 2016;92:13–24. doi:10.1016/j.biomaterials.2016.03.02627031929
   PubMed Web of Science ®Google Scholar
• Rao L, Cai B, Bu -L-L, et al. Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy. ACS Nano. 2017;11(4):3496–3505. doi:10.1021/acsnano.7b0013328272874
   PubMed Web of Science ®Google Scholar
• Li J, Wang X, Zheng D, et al. Cancer cell membrane-coated magnetic nanoparticles for MR/NIR fluorescence dual-modal imaging and photodynamic therapy. Biomater Sci. 2018;6:7. doi:10.1039/c8bm00675j
   Web of Science ®Google Scholar
• Fang RH, Hu C-MJ, Luk BT, et al. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett. 2014;14(4):2181–2188. doi:10.1021/nl500618u24673373
   PubMed Web of Science ®Google Scholar
• Hu CM, Fang RH, Copp J, Luk BT, Zhang L. A biomimetic nanosponge that absorbs pore-forming toxins. Nat Nanotechnol. 2013;8(5):336–340. doi:10.1038/nnano.2013.5423584215
   PubMed Web of Science ®Google Scholar
• Chen HW, Fang ZS, Chen YT, et al. Targeting and enrichment of viral pathogen by cell membrane cloaked magnetic nanoparticles for enhanced detection. Acs Appl Mater Inter. 2017;9:46. doi:10.1021/acsami.7b09931
   Web of Science ®Google Scholar
• Hao R, Liu J, Li Y, et al. Oxygen self-enriched nanoparticles functionalized with erythrocyte membranes for long circulation and enhanced phototherapy. Acta Biomater. 2017;59:269. doi:10.1016/j.actbio.2017.06.03528663143
   PubMedGoogle Scholar
• Luk BT, Hu C-MJ, Fang RH, et al. Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. Nanoscale. 2014;6(5):2730–2737. doi:10.1039/c3nr06371b24463706
   PubMed Web of Science ®Google Scholar
• Barclay A, Berg T. The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target. Annu Rev Immunol. 2014;32:25–50. doi:10.1146/annurev-immunol-032713-12014224215318
   PubMed Web of Science ®Google Scholar
• Jaiswal S, Jamieson CHM, Pang WW, et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell. 2009;138(2):271. doi:10.1016/j.cell.2009.07.04219632178
   PubMed Web of Science ®Google Scholar
• Cameron C, Barrett J, Mann M, Lucas A, Mcfadden G. Myxoma virus M128L is expressed as a cell surface CD47-like virulence factor that contributes to the downregulation of macrophage activation in vivo. Virology. 2005;337(1):55–67. doi:10.1016/j.virol.2005.03.03715914220
   PubMedGoogle Scholar
• Hu C-MJ, Fang RH, Luk BT, et al. ‘Marker-of-self’ functionalization of nanoscale particles through a top-down cellular membrane coating approach. Nanoscale. 2013;5(7):2664–2668. doi:10.1039/c3nr00015j23462967
   PubMed Web of Science ®Google Scholar
• Piao J-G, Wang L, Gao F, You Y-Z, Xiong Y, Yang L. Erythrocyte membrane is an alternative coating to polyethylene glycol for prolonging the circulation lifetime of gold nanocages for photothermal therapy. ACS Nano. 2014;8(10):10414–10425. doi:10.1021/nn503779d25286086
   PubMed Web of Science ®Google Scholar
• Estelrich J, Busquets MA. Iron oxide nanoparticles in photothermal therapy. Molecules. 2018;23:7. doi:10.3390/molecules23071567
   Web of Science ®Google Scholar
• Thienpont B, Steinbacher J, Zhao H, et al. Tumour hypoxia causes DNA hypermethylation by reducing TET activity. Nature. 2016;537(7618):63–68. doi:10.1038/nature1908127533040
   PubMedGoogle Scholar
• Chen H, Sha H, Zhang L, et al. Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein. Int J Nanomedicine. 2018;13:5347–5359. doi:10.2147/IJN.S16510930254439
   PubMed Web of Science ®Google Scholar
• Zhang Z, Qian H, Huang J, et al. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment. Int J Nanomedicine. 2018;13:4961–4975. doi:10.2147/IJN.S17014830214200
   PubMed Web of Science ®Google Scholar
• Zhu D-M, Xie W, Xiao Y-S, et al. Erythrocyte membrane-coated gold nanocages for targeted cancer photothermal and chemical therapy. Nanotechnology. 2017;29:8.
   Web of Science ®Google Scholar
• Trinchieri G. Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu Rev Immunol. 2012;30:677–706. doi:10.1146/annurev-immunol-020711-07500822224761
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi:10.1038/nature0720518650914
   PubMed Web of Science ®Google Scholar
• Wang Q, Ren Y, Mu J, et al. grapefruit-derived nanovectors use an activated leukocyte trafficking pathway to deliver therapeutic agents to inflammatory tumor sites. Cancer Res. 2015;75(12):2520–2529. doi:10.1158/0008-5472.CAN-14-309525883092
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9(3):162–174. doi:10.1038/nri250619197294
   PubMed Web of Science ®Google Scholar
• Murdoch C, Muthana M, Coffelt B, Lewis C. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer. 2008;8(8):618–631. doi:10.1038/nrc244418633355
   PubMed Web of Science ®Google Scholar
• Baek S-K, Makkouk AR, Krasieva T, Sun C-H, Madsen SJ, Hirschberg H. Photothermal treatment of glioma; an in vitro study of macrophage-mediated delivery of gold nanoshells. J Neuro-Oncol. 2011;104(2):439–448. doi:10.1007/s11060-010-0511-3
   PubMed Web of Science ®Google Scholar
• Parodi A, Quattrocchi N, ALvd V, et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol. 2013;8(1):61–68. doi:10.1038/nnano.2012.21223241654
   PubMed Web of Science ®Google Scholar
• Meng Q-F, Rao L, Zan M, et al. Macrophage membrane-coated iron oxide nanoparticles for enhanced photothermal tumor therapy. Nanotechnology. 2018;29(13):134004. doi:10.1088/1361-6528/aaa7c729334363
   PubMed Web of Science ®Google Scholar
• Xuan M, Shao J, Dai L, Li J, He Q. Macrophage cell membrane camouflged Au nanoshells for in vivo prolonged circulation life and enhanced cancer photothermal therapy. ACS Appl Mater Interfaces. 2016;8(15):9610–9618. doi:10.1021/acsami.6b0085327039688
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cai K, Li C, et al. Macrophage-membrane-coated nanoparticles for tumor-targeted chemotherapy. Nano Lett. 2018;18(3):1908–1915. doi:10.1021/acs.nanolett.7b0526329473753
   PubMed Web of Science ®Google Scholar
• He W, Frueh J, Wu Z, He Q. Leucocyte membrane-coated janus microcapsules for enhanced photothermal cancer treatment. Langmuir. 2016;32(15):3637–3644. doi:10.1021/acs.langmuir.5b0476227023433
   PubMedGoogle Scholar
• Zhang L, Li R, Chen H, et al. Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer. Int J Nanomedicine. 2017;12:2129–2142. doi:10.2147/IJN.S12601628360520
   PubMed Web of Science ®Google Scholar
• Coffelt SB, Kersten K, Doornebal CW, et al. IL17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature. 2015;522(7556):345–348. doi:10.1038/nature1428225822788
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg R. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi:10.1016/j.cell.2011.02.01321376230
   PubMed Web of Science ®Google Scholar
• Khaldoyanidi SK, Glinsky VV, Sikora L, et al. MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions. J Biol Chem. 2003;278(6):4127–4134. doi:10.1074/jbc.M20959020012438311
   PubMedGoogle Scholar
• Glinsky VV, Glinsky GV, Glinskii OV, et al. Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Res. 2003;63:3805–3811.12839977
   PubMed Web of Science ®Google Scholar
• Wang D, Dong H, Li M, et al. Erythrocyte-cancer hybrid membrane camouflaged hollow copper sulfide nanoparticles for prolonged circulation life and homotypic-targeting photothermal/chemotherapy of melanoma. ACS Nano. 2018.12(6);5241–5252.
   Web of Science ®Google Scholar
• Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011;11(2):123. doi:10.1038/nrc300421258396
   PubMed Web of Science ®Google Scholar
• Amo L, Tamayo-Orbegozo E, Maruri N, et al. Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein. Front Oncol. 2014;4:245. doi:10.3389/fonc.2014.0024525309871
   PubMedGoogle Scholar
• Goubran HA, Stakiw J, Radosevic M, Burnouf T. Platelet-cancer interactions. Semin Thromb Hemost. 2014;40(3):296–305. doi:10.1055/s-0034-137076724590421
   PubMed Web of Science ®Google Scholar
• Rao L, Bu -L-L, Meng Q-F, et al. Antitumor platelet-mimicking magnetic nanoparticles. Adv Funct Mater. 2017;27:9.
   Web of Science ®Google Scholar
• Zuo H, Tao J, Shi H, He J, Zhou Z, Zhang C. Platelet-mimicking nanoparticles co-loaded with W18O49 and metformin alleviate tumor hypoxia for enhanced photodynamic therapy and photothermal therapy. Acta Biomater. 2018;80(undefined):296–307. doi:10.1016/j.actbio.2018.09.01730223092
   PubMedGoogle Scholar
• Kalluru P, Vankayala R, Chiang CS, Hwang KC. Photosensitization of singlet oxygen and in vivo photodynamic therapeutic effects mediated by PEGylated W 18 O 49 nanowires. Angew Chem. 2013;52(47):12332–12336. doi:10.1002/anie.20130735824136871
   PubMedGoogle Scholar
• Dehaini D, Wei X, Fang RH, et al. Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization. Adv Mater. 2017;29(16):1606209. doi:10.1002/adma.201700681
   Web of Science ®Google Scholar
• Karnoub A, Dash A, Vo A, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007;449(7162):557–563. doi:10.1038/nature0618817914389
   PubMed Web of Science ®Google Scholar
• Au P, Tam J, Fukumura D, Jain RK. Bone marrow–derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood. 2008;111(9):4551–4558. doi:10.1182/blood-2007-10-11827318256324
   PubMedGoogle Scholar
• Quante M, Tu SP, Tomita H, et al. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell. 2011;19(2):257–272. doi:10.1016/j.ccr.2011.01.02021316604
   PubMed Web of Science ®Google Scholar
• Knoop K, Schwenk N, Schmohl K, et al. Mesenchymal stem cell (MSC)-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene. J Nucl Med. 2015;56(4):600–606. doi:10.2967/jnumed.114.14666225745085
   PubMed Web of Science ®Google Scholar
• Xu S, Menu E, De BA, Van CB, Vanderkerken K, Van RI. Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo. Stem Cells. 2012;30(2):266–279. doi:10.1002/stem.78722102554
   PubMed Web of Science ®Google Scholar
• Leibacher J, Henschler R. Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells. Stem Cell Res Ther. 2016;7(1):1–12. doi:10.1186/s13287-015-0253-426729060
   PubMedGoogle Scholar
• Seo KW, Lee HW, Oh YI, et al. Anti-tumor effects of canine adipose tissue-derived mesenchymal stromal cell-based interferon-β gene therapy and cisplatin in a mouse melanoma model. Cytotherapy. 2011;13(8):944–955. doi:10.3109/14653249.2011.58486421846298
   PubMed Web of Science ®Google Scholar
• Gao C, Lin Z, Jurado-Sánchez B, Lin X, Wu Z, He Q. Stem cell membrane-coated nanogels for highly efficient in vivo tumor targeted drug delivery. Small. 2016;12(30):4056–4062. doi:10.1002/smll.20160062427337109
   PubMed Web of Science ®Google Scholar
• Yang N, Ding Y, Zhang Y, et al. Surface functionalization of polymeric nanoparticles with umbilical cord-derived mesenchymal stem cell membrane for tumor-targeted therapy. ACS Appl Mater Interfaces. 2018;10(27):22963–22973. doi:10.1021/acsami.8b0536329905067
   PubMed Web of Science ®Google Scholar
• Gao C, Lin Z, Wu Z, Lin X, He Q. Stem-cell-membrane camouflaging on near-infrared photoactivated upconversion nanoarchitectures for in vivo remote-controlled photodynamic therapy. ACS Appl Mater Interfaces. 2016;8(50):34252. doi:10.1021/acsami.6b1286527936561
   PubMed Web of Science ®Google Scholar
• Suski JM, Lebiedzinska M, Wojtala A, et al. Isolation of plasma membrane-associated membranes from rat liver. Nat Protoc. 2014;9(2):312–322. doi:10.1038/nprot.2014.01624434800
   PubMedGoogle Scholar
• Li S-Y, Cheng H, Qiu W-X, et al. Cancer cell membrane-coated biomimetic platform for tumor targeted photodynamic therapy and hypoxia-amplified bioreductive therapy. Biomaterials. 2017;142:149–161. doi:10.1016/j.biomaterials.2017.07.02628735175
   PubMed Web of Science ®Google Scholar
• Hu C-MJ, Fang RH, Wang K-C, et al. Nanoparticle biointerfacing via platelet membrane cloaking. Nature. 2015;526(7571):118–121. doi:10.1038/nature1537326374997
   PubMed Web of Science ®Google Scholar
• Pang Z, Hu C-MJ, Fang RH, et al. Detoxification of organophosphate poisoning using nanoparticle bioscavengers. ACS Nano. 2015;9(6):6450–6458. doi:10.1021/acsnano.5b0213226053868
   PubMed Web of Science ®Google Scholar
• Zhang J, Gao W, Fang RH, Dong A, Zhang L. Synthesis of nanogels via cell membrane-templated polymerization. Small. 2015;11(34):4309–4313. doi:10.1002/smll.20150098726044721
   PubMed Web of Science ®Google Scholar
• Majeti R, Chao MP, Alizadeh AA, et al. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell. 2009;138(2):286–299. doi:10.1016/j.cell.2009.05.04519632179
   PubMed Web of Science ®Google Scholar
• Sara S, Matin MM. Cancer stem cells and cancer therapy. Tumor Biol. 2011;32(3):425–440. doi:10.1007/s13277-011-0155-8
   PubMedGoogle Scholar
• Naoya F, Satoshi T. The impact of Aggrus/podoplanin on platelet aggregation and tumour metastasis. J Biochem. 2012;152(5):407–413. doi:10.1093/jb/mvs10822992842
   PubMedGoogle Scholar
• Wang S, Li Z, Xu R. Human cancer and platelet interaction, a potential therapeutic target. Int J Mol Sci. 2018;19:4.
   Web of Science ®Google Scholar
• Yurkin ST, Wang Z. Cell membrane-derived nanoparticles: emerging clinical opportunities for targeted drug delivery. Nanomedicine. 2017;12:16. doi:10.2217/nnm-2017-0100
   Web of Science ®Google Scholar
• Yang R, Xu J, Xu L, et al. Cancer cell membrane-coated adjuvant nanoparticles with mannose modification for effective anticancer vaccination. Acs Nano. 2018.12(6):5121–5129.
   Web of Science ®Google Scholar
• Guo Y, Wang D, Song Q, et al. erythrocyte membrane-enveloped polymeric nanoparticles as nanovaccine for induction of antitumor immunity against melanoma. ACS Nano. 2015;9(7):6918. doi:10.1021/nn507282f26153897
   PubMed Web of Science ®Google Scholar
• Amani H, Habibey R, Hajmiresmail S, Latifi S, Pazoki-Toroudi H, Akhavan O. Antioxidant nanomaterials in advanced diagnoses and treatments of ischemia reperfusion injuries. J Mater Chem B. 2017;5:9452–9476. doi:10.1039/C7TB01689A
   PubMed Web of Science ®Google Scholar
• Anna S, Pitek AS, Monopoli MP, et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol. 2013;8(2):137–143. doi:10.1038/nnano.2012.23723334168
   PubMedGoogle Scholar
• Lesniak A, Fenaroli F, Monopoli MP, Åberg C, Dawson KA, Salvati A. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano. 2012;6(7):5845–5857. doi:10.1021/nn300223w22721453
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Chauhan N, Othman SF, et al. Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles. Biomaterials. 2015;46(11):1–12. doi:10.1016/j.biomaterials.2014.12.04525678111
   PubMedGoogle Scholar
• Rao L, Meng QF, Bu LL, et al. Erythrocyte membrane-coated upconversion nanoparticles with minimal protein adsorption for enhanced tumor imaging. ACS Appl Mater Interfaces. 2017;9(3):2159–2168. doi:10.1021/acsami.6b1445028050902
   PubMed Web of Science ®Google Scholar
• Bombelli FB, Webster CA, Moncrieff M, Sherwood V. The scope of nanoparticle therapies for future metastatic melanoma treatment. Lancet Oncol. 2014;15(1):e22–e32. doi:10.1016/S1470-2045(13)70333-424384491
   PubMed Web of Science ®Google Scholar
• Okazawa H, Motegi S, Ohyama N, et al. Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system. J Immunol. 2005;174(4):2004–2011.15699129
   PubMed Web of Science ®Google Scholar
• Gagneux P, Varki A. Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiology. 1999;9(8):747. doi:10.1093/glycob/9.8.74710406840
   PubMedGoogle Scholar
• Liu YS, Lin HY, Lai SW, et al. MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma. Oncogene. 2017;36:35. doi:10.1038/onc.2017.12927270441
   PubMedGoogle Scholar
• Liu X, Kwon H, Li Z, Fu Y-X. Is CD47 an innate immune checkpoint for tumor evasion? J Hematol Oncol. 2017;10(1):12. doi:10.1186/s13045-016-0381-z28077173
   PubMed Web of Science ®Google Scholar
• Coupland L, Hindmarsh E, Gardiner E, Parish C. The influence of platelet membranes on tumour cell behaviour. Cancer Metastasis Rev. 2017;36(2):215–224. doi:10.1007/s10555-017-9671-328707200
   PubMed Web of Science ®Google Scholar
• Yu L-X, Yan L, Yang W, et al. Platelets promote tumour metastasis via interaction between TLR4 and tumour cell-released high-mobility group box1 protein. Nat Commun. 2014;5(undefined):5256. doi:10.1038/ncomms597225348021
   PubMedGoogle Scholar